Eric Venker - 20 Feb 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: President & Immunovant CEO
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Issuer symbol: ROIV
Transactions as of: 20 Feb 2026
Net transactions value: -$191,435
Form type: 4
Filing time: 24 Feb 2026, 18:43:18 UTC
Previous filing: 18 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Venker Eric	President & Immunovant CEO	C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM	By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker	24 Feb 2026	0001801917

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ROIV	Common Shares	Tax liability	$191,435	-7,051	-0.43%	$27.15	1,647,546	20 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.